Position in JNJ
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,490,937
-$34,617 QoQ
Shares Held
9,808
-5.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#2,162
of 4,664 holders
Holding Since
Dec 2020
23 quarters on record
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Summit Global Investments holds $32,800,954 across 11 Drug Manufacturers - General names. JNJ ranks #4 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,407 | $12,482,469 | |
| 2 | MRK |
Merck & Co., Inc.
|
52,039 | $6,687,011 | |
| 3 | ABBV |
AbbVie Inc.
|
11,572 | $2,911,978 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
9,808 | $2,490,937 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
11,712 | $1,479,694 | |
| 6 | PFE |
Pfizer Inc
|
60,517 | $1,457,249 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
23,680 | $1,364,441 | |
| 8 | AZN |
Astrazeneca PLC
|
6,543 | $1,240,683 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,490,937 | 9,808 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $2,525,554 | 10,332 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,660,756 | 12,857 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $2,297,724 | 12,392 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $6,716,570 | 43,971 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $403,986 | 2,436 | Shares | Sole | 2025-04-07 | |
| 2024-12-31 | $388,304 | 2,685 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $770,433 | 4,754 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $637,403 | 4,361 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $695,086 | 4,394 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $740,596 | 4,725 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $756,633 | 4,858 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $722,329 | 4,364 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $685,410 | 4,422 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $769,487 | 4,356 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $714,700 | 4,375 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $812,463 | 4,577 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $811,004 | 4,576 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $787,777 | 4,605 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $735,632 | 4,555 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $750,390 | 4,555 | Shares | Sole | 2022-01-28 | |
| 2021-03-31 | $798,905 | 4,861 | Shares | Sole | 2022-01-27 | |
| 2020-12-31 | $531,157 | 3,375 | Shares | Sole | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||